Topical Brimonidine Reduces IPL-induced Erythema Without Affecting Efficacy: a Randomized Controlled Trial in Patients With Facial Telangiectasias
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Brimonidine (Primary)
- Indications Erythema
- Focus Therapeutic Use
- 03 Jan 2018 Status changed from recruiting to completed.
- 19 Apr 2016 New trial record